Author response for 'Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real‐world setting: A prospective, observational post‐marketing study' - null Lixin Guo; null Li Li; null Qiurong Yu; null Na Wang; null Jun Chen; null Yue Xi; null Huan Wang; null Yihua Wang; null Jiawei Xu (2023)